​

Chemed (CHE) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CHE Stock Forecast

Chemed (CHE) stock forecast, based on 9 Wall Street analysts, predicts a 12-month average price target of $550.00, with a high of $550.00 and a low of $550.00. This represents a 25.30% increase from the last price of $438.94.

$400 $450 $500 $550 $600 $650 High: $550 Avg: $550 Low: $550 Last Closed Price: $438.94

CHE Stock Rating

Chemed stock's rating consensus is Buy, based on 9 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (66.67%), 3 Hold (33.33%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 9 3 6 0 Strong Sell Sell Hold Buy Strong Buy

CHE Price Target Upside V Benchmarks

TypeNameUpside
StockChemed25.30%
SectorHealthcare Stocks 15.45%
IndustryMedical Care Facilities Stocks12.74%

Price Target Trends

1M3M12M
# Anlaysts-12
Avg Price Target-$550.00$591.50
Last Closing Price$438.94$438.94$438.94
Upside/Downside-25.30%34.76%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 2513---4
Sep, 25131--5
Aug, 25121--4
Jul, 2512---3
Jun, 2512---3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 02, 2025Jefferies$550.00$464.0018.53%25.30%
Nov 05, 2024Frank MorganRBC Capital$633.00$534.4118.45%44.21%
May 21, 2024Frank MorganRBC Capital$697.00$564.3423.51%58.79%
Apr 28, 2022RBC Capital$592.00$492.2520.26%34.87%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 02, 2025JefferiesHoldBuyupgrade
Jul 25, 2025JefferiesHoldinitialise
Jun 30, 2025RBC CapitalOutperformOutperformhold
May 21, 2024RBC CapitalOutperformOutperformhold
May 01, 2023RBC CapitalOutperformOutperformhold
Apr 28, 2022RBC CapitalOutperformOutperformhold

Financial Forecast

EPS Forecast

$15 $18 $21 $24 $27 $30 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$20.02$17.14$16.72$18.11$20.10---
Avg Forecast$18.07$19.16$19.67$20.71$23.08$24.89$26.32$28.18
High Forecast$18.12$19.21$19.83$20.92$23.12$25.34$26.59$28.47
Low Forecast$18.02$19.10$19.55$20.56$23.04$24.43$26.13$27.98
Surprise %10.79%-10.54%-15.00%-12.55%-12.91%---

Revenue Forecast

$2B $2B $2B $3B $3B $3B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$2.08B$2.14B$2.13B$2.26B$2.43B---
Avg Forecast$2.08B$2.14B$2.13B$2.27B$2.43B$2.60B$2.72B$2.87B
High Forecast$2.09B$2.15B$2.15B$2.28B$2.45B$2.62B$2.75B$2.90B
Low Forecast$2.08B$2.14B$2.13B$2.25B$2.41B$2.58B$2.71B$2.86B
Surprise %-0.24%-0.10%0.00%-0.03%0.16%---

Net Income Forecast

$150M $210M $270M $330M $390M $450M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$319.47M$268.55M$249.62M$272.51M$302.00M---
Avg Forecast$289.37M$248.17M$273.69M$272.51M$350.82M$378.25M$400.66M$428.34M
High Forecast$347.25M$297.81M$328.42M$327.01M$351.42M$385.11M$404.12M$432.76M
Low Forecast$231.50M$198.54M$218.95M$218.01M$350.21M$371.39M$397.21M$425.36M
Surprise %10.40%8.21%-8.79%--13.92%---

CHE Forecast FAQ

Is Chemed stock a buy?

Chemed stock has a consensus rating of Buy, based on 9 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Chemed is a favorable investment for most analysts.

What is Chemed's price target?

Chemed's price target, set by 9 Wall Street analysts, averages $550 over the next 12 months. The price target range spans from $550 at the low end to $550 at the high end, suggesting a potential 25.30% change from the previous closing price of $438.94.

How does Chemed stock forecast compare to its benchmarks?

Chemed's stock forecast shows a 25.30% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical care facilities stocks industry (12.74%).

What is the breakdown of analyst ratings for Chemed over the past three months?

  • October 2025: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 20.00% Strong Buy, 60.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 25.00% Strong Buy, 50.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.

What is Chemed’s EPS forecast?

Chemed's average annual EPS forecast for its fiscal year ending in December 2025 is $24.89, marking a 23.83% increase from the reported $20.1 in 2024. Estimates for the following years are $26.32 in 2026, and $28.18 in 2027.

What is Chemed’s revenue forecast?

Chemed's average annual revenue forecast for its fiscal year ending in December 2025 is $2.6B, reflecting a 6.89% increase from the reported $2.43B in 2024. The forecast for 2026 is $2.72B, and $2.87B for 2027.

What is Chemed’s net income forecast?

Chemed's net income forecast for the fiscal year ending in December 2025 stands at $378.25M, representing an 25.25% increase from the reported $302M in 2024. Projections indicate $400.66M in 2026, and $428.34M in 2027.